232 related articles for article (PubMed ID: 25048714)
1. Particle size determines effects of lipoprotein lipase on the catabolism of n-3 triglyceride-rich particles.
Xia L; Fan C; Dong H; Wang C; Lu Y; Deckelbaum RJ; Qi K
Clin Nutr; 2015 Aug; 34(4):767-74. PubMed ID: 25048714
[TBL] [Abstract][Full Text] [Related]
2. Omega-3 triglycerides modify blood clearance and tissue targeting pathways of lipid emulsions.
Qi K; Seo T; Al-Haideri M; Worgall TS; Vogel T; Carpentier YA; Deckelbaum RJ
Biochemistry; 2002 Mar; 41(9):3119-27. PubMed ID: 11863451
[TBL] [Abstract][Full Text] [Related]
3. Omega-3 fatty acid containing diets decrease plasma triglyceride concentrations in mice by reducing endogenous triglyceride synthesis and enhancing the blood clearance of triglyceride-rich particles.
Qi K; Fan C; Jiang J; Zhu H; Jiao H; Meng Q; Deckelbaum RJ
Clin Nutr; 2008 Jun; 27(3):424-30. PubMed ID: 18362042
[TBL] [Abstract][Full Text] [Related]
4. Effects of particle size on blood clearance and tissue uptake of lipid emulsions with different triglyceride compositions.
Qi K; Al-Haideri M; Seo T; Carpentier YA; Deckelbaum RJ
JPEN J Parenter Enteral Nutr; 2003; 27(1):58-64. PubMed ID: 12549600
[TBL] [Abstract][Full Text] [Related]
5. Lipoprotein lipase binds to low density lipoprotein receptors and induces receptor-mediated catabolism of very low density lipoproteins in vitro.
Medh JD; Bowen SL; Fry GL; Ruben S; Andracki M; Inoue I; Lalouel JM; Strickland DK; Chappell DA
J Biol Chem; 1996 Jul; 271(29):17073-80. PubMed ID: 8663292
[TBL] [Abstract][Full Text] [Related]
6. Kinetics of in vitro lipolysis of human very low-density lipoprotein by lipoprotein lipase.
Schreier L; Berg G; Zago V; Gonzalez AI; Wikinski R
Nutr Metab Cardiovasc Dis; 2002 Feb; 12(1):13-8. PubMed ID: 12125224
[TBL] [Abstract][Full Text] [Related]
7. Ex vivo measurement of lipoprotein lipase-dependent very low density lipoprotein (VLDL)-triglyceride hydrolysis in human VLDL: an alternative to the postheparin assay of lipoprotein lipase activity?
Pruneta V; Autran D; Ponsin G; Marcais C; Duvillard L; Verges B; Berthezene F; Moulin P
J Clin Endocrinol Metab; 2001 Feb; 86(2):797-803. PubMed ID: 11158049
[TBL] [Abstract][Full Text] [Related]
8. Lipoprotein lipase- and hepatic triglyceride lipase- promoted very low density lipoprotein degradation proceeds via an apolipoprotein E-dependent mechanism.
Medh JD; Fry GL; Bowen SL; Ruben S; Wong H; Chappell DA
J Lipid Res; 2000 Nov; 41(11):1858-71. PubMed ID: 11060356
[TBL] [Abstract][Full Text] [Related]
9. ApoAV reduces plasma triglycerides by inhibiting very low density lipoprotein-triglyceride (VLDL-TG) production and stimulating lipoprotein lipase-mediated VLDL-TG hydrolysis.
Schaap FG; Rensen PC; Voshol PJ; Vrins C; van der Vliet HN; Chamuleau RA; Havekes LM; Groen AK; van Dijk KW
J Biol Chem; 2004 Jul; 279(27):27941-7. PubMed ID: 15090553
[TBL] [Abstract][Full Text] [Related]
10. In vivo and in vitro properties of an intravenous lipid emulsion containing only medium chain and fish oil triglycerides.
Ton MN; Chang C; Carpentier YA; Deckelbaum RJ
Clin Nutr; 2005 Aug; 24(4):492-501. PubMed ID: 16054521
[TBL] [Abstract][Full Text] [Related]
11. Lipoprotein lipase activity does not predict very low-density lipoprotein-triglyceride fatty acid oxidation during exercise.
Søndergaard E; Andersen IR; Sørensen LP; Gormsen LC; Nielsen S
Scand J Med Sci Sports; 2017 May; 27(5):474-481. PubMed ID: 28207959
[TBL] [Abstract][Full Text] [Related]
12. Chylomicron- and VLDL-derived lipids enter the heart through different pathways: in vivo evidence for receptor- and non-receptor-mediated fatty acid uptake.
Bharadwaj KG; Hiyama Y; Hu Y; Huggins LA; Ramakrishnan R; Abumrad NA; Shulman GI; Blaner WS; Goldberg IJ
J Biol Chem; 2010 Dec; 285(49):37976-86. PubMed ID: 20852327
[TBL] [Abstract][Full Text] [Related]
13. Differential binding of triglyceride-rich lipoproteins to lipoprotein lipase.
Xiang SQ; Cianflone K; Kalant D; Sniderman AD
J Lipid Res; 1999 Sep; 40(9):1655-63. PubMed ID: 10484612
[TBL] [Abstract][Full Text] [Related]
14. Triglycerides in fish oil affect the blood clearance of lipid emulsions containing long- and medium-chain triglycerides in mice.
Qi K; Seo T; Jiang Z; Carpentier YA; Deckelbaum RJ
J Nutr; 2006 Nov; 136(11):2766-72. PubMed ID: 17056798
[TBL] [Abstract][Full Text] [Related]
15. Lipoprotein particle distribution and skeletal muscle lipoprotein lipase activity after acute exercise.
Harrison M; Moyna NM; Zderic TW; O'Gorman DJ; McCaffrey N; Carson BP; Hamilton MT
Lipids Health Dis; 2012 Jul; 11():64. PubMed ID: 22672707
[TBL] [Abstract][Full Text] [Related]
16. Very-low-density lipoprotein-induced triglyceride accumulation in human mesangial cells is mainly mediated by lipoprotein lipase.
Li J; Li H; Wen YB; Li XW
Nephron Physiol; 2008; 110(1):p1-10. PubMed ID: 18698144
[TBL] [Abstract][Full Text] [Related]
17. Resistance of chylomicron and VLDL remnants to post-heparin lipolysis in ApoE-deficient mice: the role of apoE in lipoprotein lipase-mediated lipolysis in vivo and in vitro.
Zsigmond E; Fuke Y; Li L; Kobayashi K; Chan L
J Lipid Res; 1998 Sep; 39(9):1852-61. PubMed ID: 9741698
[TBL] [Abstract][Full Text] [Related]
18. Progression of Chronic Kidney Disease Affects HDL Impact on Lipoprotein Lipase (LPL)-Mediated VLDL Lipolysis Efficiency.
Ćwiklińska A; Cackowska M; Wieczorek E; Król E; Kowalski R; Kuchta A; Kortas-Stempak B; Gliwińska A; Dąbkowski K; Zielińska J; Dębska-Ślizień A; Jankowski M
Kidney Blood Press Res; 2018; 43(3):970-978. PubMed ID: 29913451
[TBL] [Abstract][Full Text] [Related]
19. Inactive lipoprotein lipase (LPL) alone increases selective cholesterol ester uptake in vivo, whereas in the presence of active LPL it also increases triglyceride hydrolysis and whole particle lipoprotein uptake.
Merkel M; Heeren J; Dudeck W; Rinninger F; Radner H; Breslow JL; Goldberg IJ; Zechner R; Greten H
J Biol Chem; 2002 Mar; 277(9):7405-11. PubMed ID: 11751882
[TBL] [Abstract][Full Text] [Related]
20. Hypoalbuminemia and proteinuria contribute separately to reduced lipoprotein catabolism in the nephrotic syndrome.
Shearer GC; Stevenson FT; Atkinson DN; Jones H; Staprans I; Kaysen GA
Kidney Int; 2001 Jan; 59(1):179-89. PubMed ID: 11135070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
